BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 5143287)

  • 1. [Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
    Utkin VV; Zankisova IG; Poleshchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1971 Nov; 11():79-81. PubMed ID: 5143287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protionamide in the treatment of pulmonary tuberculosis].
    Kalabukha AV; Bialik IB; Mamolat AS
    Vrach Delo; 1972 May; 5():31-3. PubMed ID: 5029793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of patients with pulmonary tuberculosis, complicated by peptic ulcer, with ethionamide and prothionamide].
    Samtsov VS
    Probl Tuberk; 1973; 51(7):67-70. PubMed ID: 4767522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-radiological observations and biological studies in patients with pulmonary tuberculosis treated with prothionamide].
    Lenci E; Perko V; Falaschi C
    G Pneumol; 1970 Dec; 14(4):249-63. PubMed ID: 5526261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity of serum aldolase and transaminase in patients with chronic destructive forms of pulmonary tuberculosis during treatment with prothionamide].
    Kalabukha AV; Izabolinskaia RM
    Probl Tuberk; 1973; 51(1):46-8. PubMed ID: 4378388
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Vrach Delo; 1973 Nov; 11():97-100. PubMed ID: 4206857
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
    Gupta DK; Mital OP; Agarwal MC; Kansal HM; Nath S
    J Indian Med Assoc; 1977 Jan; 68(2):25-9. PubMed ID: 326974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1975; (5):70-3. PubMed ID: 1144350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intermittent method of treatment of patients with pulmonary tuberculosis showing poor tolerance of antitubercular agents].
    Sushkin AG
    Vrach Delo; 1973 Nov; 11():94-7. PubMed ID: 4786944
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemoprevention and preventive chemotherapy of tuberculosis in adulthood (Review)].
    Radenbach KL
    Prax Pneumol; 1974 Dec; 28 Suppl():954-63. PubMed ID: 4617218
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association.
    Tubercle; 1968 Jun; 49(2):125-35. PubMed ID: 5243159
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tolerance of ethionamide in patients with tuberculosis complicated by peptic ulcer and chronic gastritis].
    Petrenko VM
    Vrach Delo; 1977 Aug; (8):61-5. PubMed ID: 919450
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our initial results of the utilization of Th 1321 in the treatment of pulmonary tuberculosis].
    Vidal J; Fourcade J; Guin JJ; Michel FB
    Mars Med; 1966; 103(11):801-6. PubMed ID: 5991812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.